Current Treatments for Lupus
Resolve is developing a drug called RSLV-132 to treat both of these diseases and is currently conducting clinical research studies in patients with both diseases. The approach that Resolve has taken relies on fundamental research that has identified specific molecules that may be inappropriately triggering the immune system and causing the chronic inflammation seen in these diseases. By removing just these inflammatory molecules without shutting down the immune system we hope to decrease inflammation associated with lupus and Sjögren’s while not causing the side effects associated with blocking the entire immune system. Learn more.
To learn more about the clinical trial, call 888-391-7570
If you live close to one of these 12 leading rheumatology clinical study sites and would like to learn more about the clinical trial, please call the toll-free number above and a Resolve Therapeutics representative will be happy to speak with you to answer questions and provide more information.